Zura Bio Limited

NASDAQ:ZURA

Biotechnology

Healthcare
$0.97 +1.93%

+$0.07 today

Market cap
$92.96M
Beta
0.03
P/E (TTM)
-5.5
EPS (TTM)
-$0.67
52W Low $1.00High $7.44

Volume 3.02M

Average 0.75M

Returns on capital

Zura Bio Limited management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-67.6%

avg -23.7%

ROIC

-74.1%

avg 264.4%

ROA

-60.2%

avg -126.5%

Analysis

ROA is currently the strongest return metric at -60.2% versus its period average of -126.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Kimberly Ann Davis

Chief Operating Officer, Chief Legal Officer & Corporate SecretaryUSD 807.2K58——

Kiran Nistala MBBS

Chief Medical Officer & Head of DevelopmentUSD 691.15K53——

Sandeep Chidambar Kulkarni

Co-Founder, CEO & DirectorUSD 55.55K45894.00K1.37%

Gary Whale

Chief Technology Officer—52263.00K0.40%

Marlyn Mathew

VP of Finance & Accounting and Principal Financial & Accounting Officer—42——

Theresa Lowry

Chief Human Resources Officer—52——

Muzammil Mustufa

Chief Business Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Apr 1, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$12.50M

Sells

0

$0.00

Net Transaction Value

+$12.50M

Net buying

Most Active

AI Biotechnology LLC

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Feb 26, 26

AI Biotechnology LLC

Direct

Buy$12.5M

Summary

Insiders reported 1 buys worth $12.50M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $12.50M. AI Biotechnology LLC was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Zura Bio Limited compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ZURA's management, answered from reported figures.

Who manages ZURA?

Zura Bio Limited (ZURA) lists 7 active executives. The top listed executive is Gary Whale, Chief Technology Officer.

Are ZURA insiders buying or selling?

Recent insider activity shows net buying of $56.40M.